The UK Home Care market is currently valued at c.£5.6bn and is projected to reach £6.7bn by 2029,1 with the Complex Home Care market estimated to be worth c. £1.3bn.2
Key factors driving this growth include:
- Ageing Population: By 2030, over 60’s are set to increase by 3.1 million in the UK (up 18.9% since 2020), straining healthcare and care services due to rising chronic diseases.
- Cost Reduction: Amid rising healthcare costs, home care is seen as a cost-effective alternative to hospitals and residential facilities.
- Medical Advancements: New technologies allow complex care at home, expanding the market, for example with remote patient monitoring.
- Local Authority (LA) and Integrated Care Board (ICB) Support: To ease hospital pressure, LAs and ICBs advocate for complex care at home, leading to increased spending on home care packages.
- Care Quality Commission’s Quality Ranking: The CQC mandatory ranking system drives competition by emphasizing service quality improvement.
Anticipating a positive growth outlook, the demand for Complex Care is ready to fuel increased M&A activity.
To learn more about the key M&A trends taking shape this year in the Complex Care space, read our latest paper.
DOWNLOAD THE FULL PAPER
If you would like to know more about the Complex Care M&A landscape after reading this paper, or have any other questions on the wider healthcare space, please do get in touch - asultan@alvarezandmarsal.com. We would be delighted to discuss this report with you, including any implications these current and longer-term market themes may have on your business and overall shareholder objectives.
Sources:
1IBISWorld, 2PANSI, POPPI, NHS Digital, LaingBuisson; A&M analysis.
The Evolving MedTech M&A Landscape: Key Drivers and Future Outlook--TEST
February 10, 2025
The MedTech sector is experiencing a dynamic shift as mergers and acquisitions (M&A) continue to reshape the industry. With evolving technological advancements, regulatory updates, and shifting market priorities, companies are leveraging strategic acquisitions to drive growth and maintain competitive advantages. Understanding these factors is essential for MedTech leaders aiming to capitalize on emerging opportunities in 2024 and beyond.
Putting it all together: flexible and innovative financing for a consumer centric renewable energy transition
November 28, 2024
As the EU charges ahead with its ambitious renewable energy targets under the REPowerEU plan, the challenge lies in turning large-scale goals into actionable solutions. Decentralized energy production through home solar panels and heat pumps is a step forward, but the question of financing remains critical. While the U.S. has seen success with solar securitization, Europe faces unique hurdles, from fragmented regulation to consumer diversity. Yet, innovative structured credit solutions offer a tailored path forward, enabling businesses to scale sustainably and unlock new opportunities in green energy financing. Discover how Alvarez & Marsal can guide you through this evolving landscape.
THE OCCUPATIONAL HEALTH M&A MARKET
November 18, 2024
According to the Institute of Public Policy Research, presenteeism, or working whilst sick, cost the UK economy £25bn in 2023, whilst absenteeism cost an additional £5bn. To address these challenges, many workplaces now emphasise proactive, value-added services for employee wellbeing and performance, delivered both on-site and online. This shift has spurred growth in the Occupational Health market, attracting significant interest from financial investors and strategic acquirers.
Alvarez & Marsal hires Tech M&A Managing Director
November 14, 2024
London, 4 November 2024 – Leading global professional services firm Alvarez & Marsal (A&M) continues to strengthen its Corporate Finance practice in the UK with the appointment of Ian Birch as a Managing Director in Birmingham. At A&M, he will build out the practice’s technology M&A capability across Europe.
